Guidelines

The British Association for the Study of Headache

Learn MoreOur Newsletter

Download BASH Guidelines PDF.

DOWNLOAD

Download BASH Headache Proforma.

DOWNLOAD

Headache Diaries

BASH

The Migraine Trust

National Migraine Centre

Hull

Patient reported assessment scales

Headache Impact test (HIT-6TM)

Questionnaire used to assess the negative impact of headaches on normal daily activates.

6-item survey with the following domains:

  • Adverse impact of headache and social functioning
  • Role functioning
  • Vitality
  • Cognitive functioning
  • Psychological distress
  • Frequency of severe headache pain

The answers for questions are scored from never to always with five alternatives. These are scored from 6 (never) to 13 (always). The higher the patient scores, the greater the migraine impact on life.

  • Can be used in both chronic and episodic migraines
  • Recall period: 4 weeks

Migraine-specific Quality of Life Questionnaire (MSQ2.1)

14-item questionnaire with the following domains:

  • Role restrictive
  • Role preventive
  • Emotional function

Answers to questions are scaled from 1 to 6 with score 1 indicating poor and score 6 best functioning.

  • Can be used in both chronic and episodic migraines
  • Recall period: 4 weeks

Migraine Disability Assessment Scale (MIDAS):

MIDAS measures headache-related disability with a 5-item questionnaire

The three domains assessed include:

  • Everyday activities in work
  • Everyday activities at home
  • Leisure activities

Answers to domains 1 to 5 are scored by number of days. The number of days from each question are added together to form total number of days. Based on the total days, a MIDAS Grade I-IV is created. Grade I indicates mild or no disability (low number of total days) and Grade IV indicates severe disability (high number of total days).

  • Can be used in chronic and episodic migraine
  • Recall period: 3 months

Headache Treatments

BASH

See our guideline section for NICE technology appraisals and guidance.

Preventative medicines taken to prevent migraine attacks.

NICE approved CGRP Monoclonal Antibody treatments

Other non-oral treatment options

The Migraine Trust
Cefaly
electroCore
eNeura

Recent NICE approval: GEPANTS

NICE Atogepant
NICE Rimegepant

Site made by GOSSH expert 2xN

We use cookies to allow us to better understand how the site is used. By continuing to use this site, you consent to this policy. Click to learn more

I Agree